Pharmaceutical Product Supply – Activated Charcoal Suspension

The contract requires the manufacture, packaging, labeling, and delivery of activated charcoal suspension identified by NSN 7540-01-152-8070, with strict adherence to FDA current Good Manufacturing Practices and all applicable federal procurement regulations. The product must meet quality and safety standards expected for government use, ensuring consistency, sterility, and traceability throughout the production and supply chain. The subcontract is issued under the Department of Defense through the Defense Logistics Agency, with the NAICS code 325412 indicating pharmaceutical preparation manufacturing as the primary industry classification. Performance of the contract spans the full lifecycle of the product, from active ingredient processing through to final packaging and delivery, with no specified location for performance but with full compliance expected to federal and military supply protocols. The contract is listed as a subcontract under a broader procurement initiative dated July 29, 2026, and is accessible through the DIBBS system with the referenced contract and delivery order numbers, indicating its integration into the Defense Department’s logistics framework for medical supply readiness.